Supply Of Exclusive Medicines With Active Ingredients Laronidase, Vandetanib, Imiglucerase, Agalsidase Beta, Rasburicase, Sarilumab, Alemtuzumab, Alglucosidase Alfa (Etc.) From The Pharmaceutical Laboratory Sanofi Aventis, S.A.

Servicio Murciano de Salud - Junta de Compras Spain has Released a tender for Supply Of Exclusive Medicines With Active Ingredients Laronidase, Vandetanib, Imiglucerase, Agalsidase Beta, Rasburicase, Sarilumab, Alemtuzumab, Alglucosidase Alfa (Etc.) From The Pharmaceutical Laboratory Sanofi Aventis, S.A. in Pharmaceuticals. The tender was released on Jul 30, 2024.

Country - Spain

Summary - Supply Of Exclusive Medicines With Active Ingredients Laronidase, Vandetanib, Imiglucerase, Agalsidase Beta, Rasburicase, Sarilumab, Alemtuzumab, Alglucosidase Alfa (Etc.) From The Pharmaceutical Laboratory Sanofi Aventis, S.A.

Deadline - login to view

MT reference number - 19641310

Product classification - Thyroid therapy medicinal products

Organization Details:

  Address - Spain

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 19641310

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Supply of Exclusive Medicines with Active Ingredients Laronidase, Vandetanib, Imiglucerase, Agalsidase Beta, Rasburicase, Sarilumab, Alemtuzumab, Alglucosidase Alfa (etc.) from the Pharmaceutical Laboratory Sanofi Aventis, S.A.local titl e:: Suministro de Medicamentos Exclusivos con Principios activos Laronidasa, Vandetanib, Imiglucerasa, Agalsidasa Beta, Rasburicasa, Sarilumab, Alemtuzumab, Alglucosidasa Alfa ( etc.) del Laboratorio Farmacéutico Sanofi Aventis, S.A.grossbudgeteuro: 39450057.75.netbudgeteuro: 14611132.5.grossbudgetlc: 39450057.75.netbudgetlc: 14611132.5.est_amount: 39450057.75.

Mt Ref Id - 19641310

Deadline - Nov 30, -0001

Share

Similar Tenders :